The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup
Abstract
Purpose: To evaluate prognostic factors for relapse-free survival (RFS) and overall survival (OS) and to assess the impact of different postremission therapies in adult patients with core binding factor (CBF) acute myeloid leukemias (AML). Patients and Methods: Individual patient data–based meta-analysis was performed on 392 adults (median age, 42 years; range, 16 to 60 years) with CBF AML (t(8;21), n = 191; inv(16), n = 201) treated between 1993 and 2002 in prospective German AML treatment trials. Results: RFS was 60% and 58% and OS was 65% and 74% in the t(8;21) and inv(16) groups after 3 years, respectively. For postremission therapy, intention-to-treat analysis revealed no difference between intensive chemotherapy and autologous transplantation in the t(8;21) group and between chemotherapy, autologous, and allogeneic transplantation in the inv(16) group. In the t(8;21) group, significant prognostic variables for longer RFS and OS were lower WBC and higher platelet counts; loss of the Y chromosome in male patients was prognostic for shorter OS. In the inv(16) group, trisomy 22 was a significant prognostic variable for longer RFS. For patients who experienced relapse, second complete remission rate was significantly lower in patients with t(8;21), resulting in a significantly inferior survival duration after relapse compared with patients with inv(16). Conclusion: We provide novel prognostic factors for CBF AML and show that patients with t(8;21) who experience relapse have an inferior survival duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Cheson, B. D., Bennett, J. M., Kopecky, K. J., Büchner, T., Willman, C. L., Estey, E. H., Schiffer, C. A., Doehner, H., Tallman, M. S., Lister, T. A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.036 · Cited by 2,654
Self-citationCreutzig, U., & Kaspers, G. J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.116 · Cited by 2,137
ISCN 1995 An international system for human cytogenetic nomenclature
Mitelman, F. (1995) · Cited by 1,930
Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schäkel, U., Platzbecker, U., Wermke, M., Bornhäuser, M., Ritter, M., Neubauer, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4326 · Cited by 1,735
Self-citationByrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Bloomfield, C. D., Lawrence, D. D., Byrd, J. C., Carroll, A. J., Pettenati, M. J., Tantravahi, R. V., Patil, S., Davey, F. R., Berg, D. T., Schiffer, C. A., et al. (1998) · PubMed · Cited by 682
Maximally Selected Rank Statistics
Lausen, B., & Schumacher, M. (1992) · Biometrics · doi:10.2307/2532740 · Cited by 643
Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., & Rowley, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309153091103 · Cited by 492
Schoch, C., Schnittger, S., Klaus, M., Kern, W., Hiddemann, W., & Haferlach, T. (2003) · Blood · doi:10.1182/blood-2003-02-0434 · Cited by 352
Schoch, C., Kohlmann, A., Schnittger, S., Brors, B., Dugas, M., Mergenthaler, S., Kern, W., Hiddemann, W., Eils, R., & Haferlach, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142103599 · Cited by 274
Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.
Tallman, M. S., Hakimian, D., Shaw, J. M., Lissner, G. S., Russell, E. J., & Variakojis, D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.690 · Cited by 246
Kita, K., Nakase, K., Miwa, H., Masuya, M., Nishii, K., Morita, N., Takakura, N., Otsuji, A., Shirakawa, S., & Ueda, T. (1992) · Blood · doi:10.1182/blood.v80.2.470.470 · Cited by 234
Delaunay, J. (2003) · Blood · doi:10.1182/blood-2002-11-3527 · Cited by 198
Censoring distributions as a measure of follow‐up in survival analysis
Korn, E. L. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050306 · Cited by 166
Schlenk, R. F., Benner, A., Hartmann, F., del Valle, F., Weber, C., Pralle, H., Fischer, J. T., Gunzer, U., Pezzutto, A., Weber, W. P., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403009 · Cited by 119
Self-citationFröhling, S., Skelin, S., Liebisch, C., Scholl, C., Schlenk, R. F., Döhner, H., & Döhner, K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.155 · Cited by 109
Self-citationTranslocation (8;21)(q22;q22) in Acute Nonlymphocytic Leukemia
Hagemeijer, A., Garson, O. M., & Kondo, K. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(84)80007-2 · Cited by 75
Schaich, M. A., Ritter, M., Illmer, T., Lisske, P., Thiede, C., Schäkel, U., Mohr, B., Ehninger, G., & Neubauer, A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02562.x · Cited by 56
Self-citationRitter, M., Thiede, C., Schäkel, U., Schmidt, M., Alpen, B., Pascheberg, U., Mohr, B., Ehninger, G., Neubauer, A., & for the AML‐SHG study group (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2933107.x · Cited by 50
Self-citationThe AML1 and ETO Genes in Acute Myeloid Leukemia with a t(8;21)
Nucifora, G., & Rowley, J. D. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409049690 · Cited by 45
Cited by
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationGrimwade, D., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., Burnett, A. K., & on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,938
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
Schlenk, R. F., Döhner, K., Krauter, J., Fröhling, S., Corbacioglu, A., Bullinger, L., Habdank, M., Späth, D., Morgan, M., Benner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074306 · Cited by 1,628
Self-citationEstey, E., & Döhner, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69780-8 · Cited by 1,296
Self-citationRole of RUNX1 in hematological malignancies
Sood, R., Kamikubo, Y., & Liu, P. (2017) · Blood · doi:10.1182/blood-2016-10-687830 · Cited by 494
Metadata
- Authors
- Schlenk, R. F., Benner, A., Krauter, J., Büchner, T., Sauerland, C., Ehninger, G., Schaich, M., Mohr, B., Niederwieser, D., Krahl, R., Pasold, R., Döhner, K., Ganser, A., Döhner, H., & Heil, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-09-15
- Volume
- 22
- Issue
- 18
- Pages
- 3741-3750
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2103513114
- Cited by
- 356
- References
- 27
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.